Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 321

1.

Competitive Bodybuilding: Fitness, Pathology, or Both?

Steele IH, Pope HG Jr, Kanayama G.

Harv Rev Psychiatry. 2019 Jul/Aug;27(4):233-240. doi: 10.1097/HRP.0000000000000211.

PMID:
31219882
2.

Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Kaufman MJ, Kanayama G, Hudson JI, Pope HG Jr.

Neurosci Biobehav Rev. 2019 May;100:180-207. doi: 10.1016/j.neubiorev.2019.02.014. Epub 2019 Feb 25. Review.

PMID:
30817935
3.

The CASTRO study: Unsafe sexual behaviors and illicit drug use among gay and bisexual men who use anabolic steroids.

Ip EJ, Doroudgar S, Shah-Manek B, Barnett MJ, Tenerowicz MJ, Ortanez M, Pope HG Jr.

Am J Addict. 2019 Feb;28(2):101-110. doi: 10.1111/ajad.12865. Epub 2019 Feb 6.

PMID:
30724428
4.

Use of an Individual-Level Approach to Identify Cortical Connectivity Biomarkers in Obsessive-Compulsive Disorder.

Brennan BP, Wang D, Li M, Perriello C, Ren J, Elias JA, Van Kirk NP, Krompinger JW, Pope HG Jr, Haber SN, Rauch SL, Baker JT, Liu H.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Jan;4(1):27-38. doi: 10.1016/j.bpsc.2018.07.014. Epub 2018 Aug 16.

PMID:
30262337
5.

The Health Threat Posed by the Hidden Epidemic of Anabolic Steroid Use and Body Image Disorders Among Young Men.

Goldman AL, Pope HG, Bhasin S.

J Clin Endocrinol Metab. 2019 Apr 1;104(4):1069-1074. doi: 10.1210/jc.2018-01706.

PMID:
30239802
6.

Evolving Perspectives on the Public Health Burden of Eating Disorders.

Hudson JI, Pope HG Jr.

Biol Psychiatry. 2018 Sep 1;84(5):318-319. doi: 10.1016/j.biopsych.2018.06.011. No abstract available.

PMID:
30115240
7.

Aging male symptomatology and eating behavior.

Kummer KK, Pope HG, Hudson JI, Kemmler G, Pinggera GM, Mangweth-Matzek B.

Aging Male. 2019 Mar;22(1):55-61. doi: 10.1080/13685538.2018.1477931. Epub 2018 Jun 4.

PMID:
29863438
8.

A Survey of American Psychiatrists' Attitudes Toward Classic Hallucinogens.

Barnett BS, Siu WO, Pope HG Jr.

J Nerv Ment Dis. 2018 Jun;206(6):476-480. doi: 10.1097/NMD.0000000000000828.

PMID:
29781894
9.

Associations of anabolic-androgenic steroid use with other behavioral disorders: an analysis using directed acyclic graphs.

Kanayama G, Pope HG, Hudson JI.

Psychol Med. 2018 Nov;48(15):2601-2608. doi: 10.1017/S0033291718000508. Epub 2018 Mar 1.

PMID:
29490719
10.

Public health impact of androgens.

Kanayama G, Kaufman MJ, Pope HG Jr.

Curr Opin Endocrinol Diabetes Obes. 2018 Jun;25(3):218-223. doi: 10.1097/MED.0000000000000404. Review.

11.

Acute change in anterior cingulate cortex GABA, but not glutamine/glutamate, mediates antidepressant response to citalopram.

Brennan BP, Admon R, Perriello C, LaFlamme EM, Athey AJ, Pizzagalli DA, Hudson JI, Pope HG Jr, Jensen JE.

Psychiatry Res Neuroimaging. 2017 Nov 30;269:9-16. doi: 10.1016/j.pscychresns.2017.08.009. Epub 2017 Sep 1.

12.

Doping in Two Elite Athletics Competitions Assessed by Randomized-Response Surveys.

Ulrich R, Pope HG Jr, Cléret L, Petróczi A, Nepusz T, Schaffer J, Kanayama G, Comstock RD, Simon P.

Sports Med. 2018 Jan;48(1):211-219. doi: 10.1007/s40279-017-0765-4.

PMID:
28849386
13.

Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use.

Baggish AL, Weiner RB, Kanayama G, Hudson JI, Lu MT, Hoffmann U, Pope HG Jr.

Circulation. 2017 May 23;135(21):1991-2002. doi: 10.1161/CIRCULATIONAHA.116.026945.

14.

Polypharmacy, Infectious Diseases, Sexual Behavior, and Psychophysical Health Among Anabolic Steroid-Using Homosexual and Heterosexual Gym Patrons in San Francisco's Castro District.

Ip EJ, Yadao MA, Shah BM, Doroudgar S, Perry PJ, Tenerowicz MJ, Newsom L, Mann AA, Mkrtchyan H, Pope HG Jr.

Subst Use Misuse. 2017 Jun 7;52(7):959-968. doi: 10.1080/10826084.2016.1267224. Epub 2017 Mar 15.

PMID:
28296533
15.

History and epidemiology of anabolic androgens in athletes and non-athletes.

Kanayama G, Pope HG Jr.

Mol Cell Endocrinol. 2018 Mar 15;464:4-13. doi: 10.1016/j.mce.2017.02.039. Epub 2017 Mar 1. Review.

PMID:
28245998
16.

White matter abnormalities in long-term anabolic-androgenic steroid users: A pilot study.

Seitz J, Lyall AE, Kanayama G, Makris N, Hudson JI, Kubicki M, Pope HG Jr, Kaufman MJ.

Psychiatry Res Neuroimaging. 2017 Feb 28;260:1-5. doi: 10.1016/j.pscychresns.2016.12.003. Epub 2016 Dec 10.

17.

Body Image Disorders and Abuse of Anabolic-Androgenic Steroids Among Men.

Pope HG Jr, Khalsa JH, Bhasin S.

JAMA. 2017 Jan 3;317(1):23-24. doi: 10.1001/jama.2016.17441. No abstract available.

PMID:
27930760
18.

Eating disorder symptoms in middle-aged and older men.

Mangweth-Matzek B, Kummer KK, Pope HG.

Int J Eat Disord. 2016 Oct;49(10):953-957. doi: 10.1002/eat.22550. Epub 2016 May 13.

PMID:
27173753
19.

LOWER POSTERIOR CINGULATE CORTEX GLUTATHIONE LEVELS IN OBSESSIVE-COMPULSIVE DISORDER.

Brennan BP, Jensen JE, Perriello C, Pope HG Jr, Jenike MA, Hudson JI, Rauch SL, Kaufman MJ.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Feb 1;1(2):116-124.

20.

Ruptured Tendons in Anabolic-Androgenic Steroid Users: A Cross-Sectional Cohort Study.

Kanayama G, DeLuca J, Meehan WP 3rd, Hudson JI, Isaacs S, Baggish A, Weiner R, Micheli L, Pope HG Jr.

Am J Sports Med. 2015 Nov;43(11):2638-44. doi: 10.1177/0363546515602010. Epub 2015 Sep 11.

21.

Anti-Social Behaviors Associated with Anabolic-Androgenic Steroid Use among Male Adolescents.

Hallgren M, Pope HG Jr, Kanayama G, Hudson JI, Lundin A, Källmén H.

Eur Addict Res. 2015;21(6):321-6. doi: 10.1159/000433580. Epub 2015 Jun 19.

PMID:
26113433
22.

Brain and cognition abnormalities in long-term anabolic-androgenic steroid users.

Kaufman MJ, Janes AC, Hudson JI, Brennan BP, Kanayama G, Kerrigan AR, Jensen JE, Pope HG Jr.

Drug Alcohol Depend. 2015 Jul 1;152:47-56. doi: 10.1016/j.drugalcdep.2015.04.023. Epub 2015 May 7.

23.

An Examination of Rostral Anterior Cingulate Cortex Function and Neurochemistry in Obsessive-Compulsive Disorder.

Brennan BP, Tkachenko O, Schwab ZJ, Juelich RJ, Ryan EM, Athey AJ, Pope HG, Jenike MA, Baker JT, Killgore WD, Hudson JI, Jensen JE, Rauch SL.

Neuropsychopharmacology. 2015 Jul;40(8):1866-76. doi: 10.1038/npp.2015.36. Epub 2015 Feb 9.

24.

Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem.

Kanayama G, Hudson JI, DeLuca J, Isaacs S, Baggish A, Weiner R, Bhasin S, Pope HG Jr.

Addiction. 2015 May;110(5):823-31. doi: 10.1111/add.12850. Epub 2015 Feb 25.

25.

REDUCED DISGUST PROPENSITY IS ASSOCIATED WITH IMPROVEMENT IN CONTAMINATION/WASHING SYMPTOMS IN OBSESSIVE-COMPULSIVE DISORDER.

Athey AJ, Elias JA, Crosby JM, Jenike MA, Pope HG Jr, Hudson JI, Brennan BP.

J Obsessive Compuls Relat Disord. 2015 Jan 1;4:20-24.

26.

Pathological eating and body dissatisfaction in middle-aged and older women.

Mangweth-Matzek B, Hoek HW, Pope HG Jr.

Curr Opin Psychiatry. 2014 Nov;27(6):431-5. doi: 10.1097/YCO.0000000000000102. Review.

PMID:
25247455
27.

Intensive residential treatment for severe obsessive-compulsive disorder: characterizing treatment course and predictors of response.

Brennan BP, Lee C, Elias JA, Crosby JM, Mathes BM, Andre MC, Gironda CM, Pope HG Jr, Jenike MA, Fitzmaurice GM, Hudson JI.

J Psychiatr Res. 2014 Sep;56:98-105. doi: 10.1016/j.jpsychires.2014.05.008. Epub 2014 May 23.

28.

Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Pope HG Jr, Wood RI, Rogol A, Nyberg F, Bowers L, Bhasin S.

Endocr Rev. 2014 Jun;35(3):341-75. doi: 10.1210/er.2013-1058. Epub 2013 Dec 17. Review.

29.

Prevalence of eating disorders in middle-aged women.

Mangweth-Matzek B, Hoek HW, Rupp CI, Lackner-Seifert K, Frey N, Whitworth AB, Pope HG, Kinzl J.

Int J Eat Disord. 2014 Apr;47(3):320-4. doi: 10.1002/eat.22232. Epub 2013 Nov 30.

PMID:
24293379
30.

The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates.

Pope HG Jr, Kanayama G, Athey A, Ryan E, Hudson JI, Baggish A.

Am J Addict. 2014 Jul-Aug;23(4):371-7. doi: 10.1111/j.1521-0391.2013.12118.x. Epub 2013 Sep 20.

31.

A placebo-controlled trial of acetyl-L-carnitine and α-lipoic acid in the treatment of bipolar depression.

Brennan BP, Jensen JE, Hudson JI, Coit CE, Beaulieu A, Pope HG Jr, Renshaw PF, Cohen BM.

J Clin Psychopharmacol. 2013 Oct;33(5):627-35. doi: 10.1097/JCP.0b013e31829a83f5.

32.

The menopausal transition--a possible window of vulnerability for eating pathology.

Mangweth-Matzek B, Hoek HW, Rupp CI, Kemmler G, Pope HG Jr, Kinzl J.

Int J Eat Disord. 2013 Sep;46(6):609-16. doi: 10.1002/eat.22157. Epub 2013 Jul 11.

PMID:
23847142
33.

Performance-enhancing drugs on the web: a growing public-health issue.

Brennan BP, Kanayama G, Pope HG Jr.

Am J Addict. 2013 Mar-Apr;22(2):158-61. doi: 10.1111/j.1521-0391.2013.00311.x. Epub 2013 Feb 1.

34.

Cognitive deficits in long-term anabolic-androgenic steroid users.

Kanayama G, Kean J, Hudson JI, Pope HG Jr.

Drug Alcohol Depend. 2013 Jun 1;130(1-3):208-14. doi: 10.1016/j.drugalcdep.2012.11.008. Epub 2012 Dec 14.

35.

National Athletic Trainers' Association position statement: anabolic-androgenic steroids.

Kersey RD, Elliot DL, Goldberg L, Kanayama G, Leone JE, Pavlovich M, Pope HG Jr; National Athletic Trainers' Association.

J Athl Train. 2012 Sep-Oct;47(5):567-88. doi: 10.4085/1062-6050-47.5.08.

36.

A critical review of magnetic resonance spectroscopy studies of obsessive-compulsive disorder.

Brennan BP, Rauch SL, Jensen JE, Pope HG Jr.

Biol Psychiatry. 2013 Jan 1;73(1):24-31. doi: 10.1016/j.biopsych.2012.06.023. Epub 2012 Jul 24. Review.

37.

Psychiatric treatment of the VIP: some paradoxical risks.

Silverman BC, Asby A, Brendel DH, Choras P, Chu JA, Holman J, Pope HG Jr, Radden J, Samson JA, Smith GW, Tsimprea G, Bodkin JA.

J Nerv Ment Dis. 2012 Jun;200(6):545-8. doi: 10.1097/NMD.0b013e318257c805.

PMID:
22652622
38.

Illicit use of androgens and other hormones: recent advances.

Kanayama G, Pope HG Jr.

Curr Opin Endocrinol Diabetes Obes. 2012 Jun;19(3):211-9. doi: 10.1097/MED.0b013e3283524008. Review.

39.

Culture, psychosomatics and substance abuse: the example of body image drugs.

Kanayama G, Hudson JI, Pope HG Jr.

Psychother Psychosom. 2012;81(2):73-8. doi: 10.1159/000330415. Epub 2012 Jan 18. No abstract available.

40.

By how much will the proposed new DSM-5 criteria increase the prevalence of binge eating disorder?

Hudson JI, Coit CE, Lalonde JK, Pope HG Jr.

Int J Eat Disord. 2012 Jan;45(1):139-41. doi: 10.1002/eat.20890. Epub 2010 Dec 10.

PMID:
22170026
41.

Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study.

Pope HG Jr, Kanayama G, Hudson JI.

Biol Psychiatry. 2012 Feb 1;71(3):254-61. doi: 10.1016/j.biopsych.2011.06.024. Epub 2011 Aug 12.

42.

Testosterone gel replacement improves sexual function in depressed men taking serotonergic antidepressants: a randomized, placebo-controlled clinical trial.

Amiaz R, Pope HG Jr, Mahne T, Kelly JF, Brennan BP, Kanayama G, Weiser M, Hudson JI, Seidman SN.

J Sex Marital Ther. 2011;37(4):243-54. doi: 10.1080/0092623X.2011.582425.

PMID:
21707327
43.

Gods, men, and muscle dysmorphia.

Kanayama G, Pope HG Jr.

Harv Rev Psychiatry. 2011 Mar-Apr;19(2):95-8. doi: 10.3109/10673229.2011.565250. No abstract available.

PMID:
21425938
44.

Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs.

Halpern JH, Sherwood AR, Hudson JI, Gruber S, Kozin D, Pope HG Jr.

Addiction. 2011 Apr;106(4):777-86. doi: 10.1111/j.1360-0443.2010.03252.x. Epub 2011 Feb 15.

45.

Human growth hormone abuse in male weightlifters.

Brennan BP, Kanayama G, Hudson JI, Pope HG Jr.

Am J Addict. 2011 Jan-Feb;20(1):9-13. doi: 10.1111/j.1521-0391.2010.00093.x. Epub 2010 Nov 12.

46.

Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users.

Schwilke EW, Gullberg RG, Darwin WD, Chiang CN, Cadet JL, Gorelick DA, Pope HG, Huestis MA.

Addiction. 2011 Mar;106(3):499-506. doi: 10.1111/j.1360-0443.2010.03228.x. Epub 2010 Dec 6.

47.

A diagnostic interview module for anabolic-androgenic steroid dependence: preliminary evidence of reliability and validity.

Pope HG, Kean J, Nash A, Kanayama G, Samuel DB, Bickel WK, Hudson JI.

Exp Clin Psychopharmacol. 2010 Jun;18(3):203-13. doi: 10.1037/a0019370.

48.

Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment.

Pope HG Jr, Amiaz R, Brennan BP, Orr G, Weiser M, Kelly JF, Kanayama G, Siegel A, Hudson JI, Seidman SN.

J Clin Psychopharmacol. 2010 Apr;30(2):126-34. doi: 10.1097/JCP.0b013e3181d207ca.

PMID:
20520285
49.

Longitudinal study of the diagnosis of components of the metabolic syndrome in individuals with binge-eating disorder.

Hudson JI, Lalonde JK, Coit CE, Tsuang MT, McElroy SL, Crow SJ, Bulik CM, Hudson MS, Yanovski JA, Rosenthal NR, Pope HG Jr.

Am J Clin Nutr. 2010 Jun;91(6):1568-73. doi: 10.3945/ajcn.2010.29203. Epub 2010 Apr 28.

50.

Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction.

Baggish AL, Weiner RB, Kanayama G, Hudson JI, Picard MH, Hutter AM Jr, Pope HG Jr.

Circ Heart Fail. 2010 Jul;3(4):472-6. doi: 10.1161/CIRCHEARTFAILURE.109.931063. Epub 2010 Apr 27.

Supplemental Content

Support Center